189 related articles for article (PubMed ID: 17067671)
1. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
Wang X; Wang C; Qin YW; Yan SK; Gao YR
Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
[TBL] [Abstract][Full Text] [Related]
2. [Drug resistance reversal of HL-60/ADR cells by simultaneous suppression of XIAP and MRP].
Wang XF; Wang C; Qin YW; Yan SK; Gao YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1110-5. PubMed ID: 17204174
[TBL] [Abstract][Full Text] [Related]
3. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line.
Wang L; Zhang GM; Feng ZH
Acta Pharmacol Sin; 2003 Dec; 24(12):1235-40. PubMed ID: 14653950
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitization effects of simultaneous suppression of MDR1 and XIAP in multidrug resistant glioma cells.
Zhang Z; Wang X; Wang S
Med Oncol; 2008; 25(4):367-73. PubMed ID: 18213456
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
Holt SV; Brookes KE; Dive C; Makin GW
Oncol Rep; 2011 Apr; 25(4):1177-81. PubMed ID: 21286665
[TBL] [Abstract][Full Text] [Related]
7. [Role of XIAP in the drug resistance of HL-60 cells].
Wang XF; Wang C; Qin YW; Yan SK; Gao YR
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):1-5. PubMed ID: 16732928
[TBL] [Abstract][Full Text] [Related]
8. Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin.
Hunáková L; Sedlák J; Suliková M; Chovancová J; Duraj J; Chorváth B
Neoplasma; 1997; 44(6):366-9. PubMed ID: 9605009
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.
Shi Z; Liang YJ; Chen ZS; Wang XH; Ding Y; Chen LM; Fu LW
Oncol Rep; 2007 Apr; 17(4):969-76. PubMed ID: 17342344
[TBL] [Abstract][Full Text] [Related]
10. Expression of the IAPs in multidrug resistant tumor cells.
Notarbartolo M; Cervello M; Poma P; Dusonchet L; Meli M; D'Alessandro N
Oncol Rep; 2004 Jan; 11(1):133-6. PubMed ID: 14654915
[TBL] [Abstract][Full Text] [Related]
11. [Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells].
Huang YY; Xia Y; Guo HX; Li WY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):204-8. PubMed ID: 18250043
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Xu D; Lu Q; Hu X
Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
[TBL] [Abstract][Full Text] [Related]
13. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
14. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T
Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415
[TBL] [Abstract][Full Text] [Related]
15. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
Li J; Liu P; Mao H; Wanga A; Zhang X
Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.
Wang R; Li B; Wang X; Lin F; Gao P; Cheng SY; Zhang HZ
Auris Nasus Larynx; 2009 Jun; 36(3):332-9. PubMed ID: 19013033
[TBL] [Abstract][Full Text] [Related]
17. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
18. Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells.
Wu YH; You Y; Chen ZC; Zou P
Acta Biochim Pol; 2008; 55(4):673-80. PubMed ID: 19093040
[TBL] [Abstract][Full Text] [Related]
19. Difloxacin reverses multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related protein (MRP) gene.
Gollapudi S; Thadepalli F; Kim CH; Gupta S
Oncol Res; 1995; 7(5):213-25. PubMed ID: 8534927
[TBL] [Abstract][Full Text] [Related]
20. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]